![Kirsten Flowers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kirsten Flowers
Directeur/Bestuurslid bij
PMV PHARMACEUTICALS, INC.
Vermogen: - $ op 31-05-2026
Profiel
Kirsten Flowers is currently an Independent Director at PMV Pharmaceuticals, Inc. since 2022 and a Director at Comera Life Sciences, Inc. Former roles include Independent Director at Comera Life Sciences Holdings, Inc., Senior Vice President-Commercial Operations at Array BioPharma, Inc. from 2017 to 2019, and Chief Commercial & Strategy Officer at Kura Oncology, Inc. from 2020 to 2023.
Education includes an undergraduate degree from the University of Arizona and an MBA from Harvard Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Kirsten Flowers
| Bedrijven | Functie | Begin |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 05-01-2022 |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Directeur/Bestuurslid | - |
Eerdere bekende functies van Kirsten Flowers
| Bedrijven | Functie | Einde |
|---|---|---|
| KURA ONCOLOGY, INC. | Corporate Officer/Principal | 27-01-2023 |
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 01-01-2019 |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Directeur/Bestuurslid | - |
Opleiding van Kirsten Flowers
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Health Technology |
Comera Life Sciences Holdings, Inc.
 Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Kies MarketScreener 
